REFERENCES
- Sakata VM, da Silva FT, Hirata CE, et al. Diagnosis and classification of Vogt–Koyanagi–Harada disease. Autoimmun Rev. 2014;13(4):550–555.
- Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39(4):265–292.
- Rao NA, Gupta A, Dustin L, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010;117(3):591–599.
- Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652.
- Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt–Koyanagi–Harada disease. Retina. 2012;32(10):2061–2069.
- Hosoda Y, Hayashi H, Kuriyama S. Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt–Koyanagi–Harada disease. Br J Ophthalmol. 2015;99(9):1211–1214.
- Hirooka K, Saito W, Namba K, et al. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids. BMC Ophthalmol. 2015;15(1):1.
- Gallagher MJ, Yilmaz T, Cervantes-Castañeda RA, et al. The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol. 2007;91(12):1680–1685.
- Agrawal R, Salman M, Tan KA, et al. Choroidal Vascularity Index (CVI): A novel optical coherence tomography parameter for monitoring patients with panuveitis? PloS One. 2016;11(1):e0146344.
- Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500.
- Agrawal R, Li LK, Nakhate V, et al. Choroidal Vascularity Index in Vogt-Koyanagi-Harada disease: An EDI-OCT derived tool for monitoring disease progression. Transl Vis Sci Technol. 2016;5(4):7.
- Drexler W, Fujimoto JG. State-of-the-art retinal optical coherence tomography. Prog Ret Eye Res. 2008;27(1):45–88.
- Regatieri CV, Branchini L, Fujimoto JG, et al. Choroidal imaging using spectral-domain optical coherence tomography. Retina. 2012;32(5):865–876.
- Huang TL, Huang SP, Chang CH, et al. Protective effects of systemic treatment with methylprednisolone in a rodent model of non-arteritic anterior ischemic optic neuropathy (rAION). Exp Eye Res. 2015;131:69–76.
- Nakai K, Gomi F, Ikuno Y, et al. Choroidal observations in Vogt–Koyanagi–Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250(7):1089–1095.
- Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt–Koyanagi–Harada disease. Retina. 2011;31(3):502–509.
- Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt–Koyanagi–Harada disease. Retina. 2011;31(3):510–517.
- Motaghiannezam R, Schwartz DM, Fraser SE. In vivo human choroidal vascular pattern visualization using high-speed swept-source optical coherence tomography at 1060 nm SS-OCT visualization of human choroidal vascular pattern. Investig Ophthalmol Vis Sci. 2012;53(4):2337–2348.
- Copete S, Flores-Moreno I, Montero JA, et al. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol. 2014;98(3):334–338.
- Adhi M, Liu JJ, Qavi AH, et al. Enhanced visualization of the choroido-scleral interface using swept-source OCT. Ophthalmic Surg Lasers Imaging Retina. 2013;44(6):S40–S42.
- Sonoda S, Sakamoto T, Yamashita T, et al. Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images. American journal of ophthalmology. 2015;159(6):1123–1131.
- Nazari H, Hariri A, Hu Z, et al. Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation. J Ophthalmic Inflamm Infect. 2014;4(1):1.
- Bittencourt MG, Kherani S, Ferraz DA, et al. Variation of choroidal thickness and vessel diameter in patients with posterior non-infectious uveitis. J Ophthalmic Inflamm Infect. 2014;4(1):1.
- Hirose S, Saito W, Yoshida K, et al. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt–Koyanagi–Harada disease. Acta Ophthalmol. 2008;86(8):902–907.
- Chan WM, Lam DS, Lai TY, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. 2003;87(12):1453–1458.
- Hosoda Y, Uji A, Hangai M, et al. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2014;157(5):1056–1063.
- Yamamoto M, Nishijima K, Nakamura M, et al. Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography. Jpn J Ophthalmol. 2011;55(1):1–6.
- Mawatari Y, Hirata A, Fukushima M, et al. Choroidal dye filling velocity in patients with Vogt–Koyanagi–Harada disease. Graefes Arch Clin Exp Ophthalmol. 2006;244(8):1056–1059.
- Nakao K, Abematsu N, Mizushima Y, et al. Optic disc swelling in Vogt-Koyanagi-Harada disease optic disc swelling in VKH. Investig Ophthalmol Vis Sci. 2012;53(4):1917–1922.
- Din NM, Taylor SR, Isa H, et al. Evaluation of retinal nerve fiber layer thickness in eyes with hypertensive uveitis. JAMA Ophthalmol. 2014;132(7):859–865.
- Shah SM, Sepah Y, Sadiq M, et al. Segmentation and analysis of retinal layers in eyes with uveitis and comparison with normal. Investig Ophthalmol Vis Sci. 2013;54(15):5205.